ACTG vs OGN · rev $168.8M vs P/E 3.4, rev $3.02B
Acacia Research Corporation (ACTG) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Acacia Research Corporation (ACTG) is a business equipment & supplies company listed on NASDAQ.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ACTG revenue for 2026-06-30 was $168.8M. Net income was -$15.7M. ACTG currently screens at market cap $452.0M.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ACTG currently screens at market cap $452.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ACTG and OGN stock pages for the full models.
Not investment advice.